Family Nurture Intervention in the NICU



Status:Recruiting
Conditions:Women's Studies, Women's Studies
Therapuetic Areas:Reproductive
Healthy:No
Age Range:Any
Updated:9/19/2018
Start Date:January 24, 2017
End Date:June 2021
Contact:Mai Mitsuyama, BA
Email:mm4584@cumc.columbia.edu
Phone:(212) 342-4400

Use our guide to learn which trials are right for you!

Family Nurture Intervention in the NICU: A Multi-Site Trial

The purpose of this study is to compare neurodevelopment and activity in infants born very
preterm (26 to 33 6/7 weeks gestational age (GA)) receiving Standard Care (SC) or Family
Nurture Intervention (FNI) in the neonatal intensive care unit (NICU).

The study investigator hypothesizes that FNI will improve: i) neonatal
electroencephalographic activity ii) maternal caregiving and wellbeing (psychological and
physiological), and iii) infant behavior and neurodevelopment at 18 months corrected age
(CA).

The two-part study aims to:

- Part I - replicate efficacy from an earlier trial by conducting the study at multiple
sites to allow for greater generalizability.

- SC, approximately 90 infants plus the parents

- FNI, approximately 90 infants plus the parents

- Term Controls, approximately 25 infants plus the parents - if enrollment not
reached, enrollment may continue in Part II

- Part II - examine effectiveness by implementing FNI unit-wide so that every baby
receives the intervention.

- FNI, approximately 90 infants plus their parents

Increasing number of studies demonstrating the importance of early mother-infant nurturing
interaction on long-term outcomes demonstrates the need for a prevention/remedial
intervention in the neonatal intensive care unit (NICU). The foremost goal of neonatal
intensive care is to ensure survival and medical stability of the infant. Within the NICU,
parental involvement in care is necessarily superseded by the healthcare staff's need to
assure survival. Thus, a necessary but detrimental separation between mother and infant is
created at a critical period when mother-infant connection and synchrony should be
developing. The physiological challenges associated with being born too soon, along with
disturbances in normal mother-infant interactions, are key factors underlying the risks of
premature infants for a broad range of early and midlife disorders.

Not only are preterm infants at increased risk for adverse outcomes (>50%), but up to 40% of
mothers of these infants suffer from depression during the postpartum period and many mothers
suffer symptoms of trauma and post-traumatic stress. Importantly, fathers of preterm infants
are also at increased for postnatal depression. In addition, a recent review of 10 studies
found that mothers of preterm infants are at increased risk for subsequent ischemic heart
disease, stroke, atherosclerosis, and death due to cardiovascular disease (CVD). Delivery of
a preterm infant has long lasting effects on both parents with both mothers and fathers
reporting increased parenting stress when their infants reached 7 years of age.

This study will allow examination of the immediate and long-term effects of new approach on
the development of preterm infants and cardiovascular risk of their parents.

For the FNI and SC Groups (enrolled competitively at across all participating sites)

Inclusion criteria:

- Infant is between 26 and 33 6/7 weeks gestational age upon admission

- Infant is a singleton or twin

Exclusion criteria:

- Infant's attending physician does not recommend enrollment in the study

- Severe congenital anomalies including chromosomal anomalies

- Ultrasound evidence of large parenchymal hemorrhagic infarction (>2 cm,
intraventricular hemorrhage grade 3 or 4)

- Infant cardiac anomalies

- Mother has known history of substance abuse, severe psychiatric illness or psychosis

- Status of enrolled subject changes and subject now falls into exclusion criteria

- Mother and/or infant has a medical condition that precludes intervention components

- Mother and/or infant has a contagion that endangers other participants in the study

For the TC Group (enrolled at one site: MSCHONY)

Inclusion Criteria:

- Infant is born between 38-42 weeks gestation

- Infant is singleton or twin

Exclusion criteria:

- Infant's attending physician does not recommend enrollment in the study

- Severe congenital anomalies including chromosomal anomalies

- Ultrasound evidence of large parenchymal hemorrhagic infarction (>2 cm,
intraventricular hemorrhage grade 3 or 4)

- Infant cardiac anomalies

- Mother has known history of substance abuse, severe psychiatric illness or psychosis

- Status of enrolled subject changes and subject now falls into exclusion criteria

- Mother and/or infant has a medical condition that precludes intervention components

- Mother and/or infant has a contagion that endangers other participants in the study
We found this trial at
3
sites
3959 Broadway
New York, New York 10032
Principal Investigator: Martha G Welch, MD
Phone: 212-342-4400
?
mi
from
New York, NY
Click here to add this to my saved trials
San Antonio, Texas 78229
Principal Investigator: Alice K Gong, MD
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
South Miami, Florida 33143
Principal Investigator: Jorge E Perez, MD
Phone: 305-205-0177
?
mi
from
South Miami, FL
Click here to add this to my saved trials